The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chuchalin A.G.

N.V. Sklifosovskiy Institute for Emergency Care, Moscow Health Department;
Institute of Pulmonology, Federal Medical and Biological Agency of Russia, Moscow, Russia

Bronchiectasis

Authors:

Chuchalin A.G.

More about the authors

Journal: Therapeutic Archive. 2017;89(3): 4‑17

DOI: 10.17116/terarkh20178934-17

Read: 13511 times

Contact the author
Table of contents

BRONCHIECTASIS
BRONCHIECTASIS

To cite this article:

Chuchalin AG. Bronchiectasis. Therapeutic Archive. 2017;89(3):4‑17. (In Russ.)
https://doi.org/10.17116/terarkh20178934-17

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Sino­nasal pathology in patients with primary ciliary dyskinesia. Russian Rhinology. 2025;(3):223-232
History of the use of CFTR modu­lators in the treatment of cystic fibrosis. Journal of Respiratory Medi­cine. 2025;(3):40-50
Combination of bronchial asthma with bronchiectasis. (Clinical case repo­rts). Journal of Respiratory Medi­cine. 2025;(4):47-52
Hearing impairment in children with cystic fibrosis. Russian Bulletin of Otorhinolaryngology. 2026;(1):41-49
News in mole­cular biology. Digest of scientific publications. Issue 4. Labo­ratory Service. 2026;(2):5-7
Biophysical mechanisms of muco­stasis in the airways and their mode­ling: the role of osmo­tic bala­nce and the «gel on brush» model. Journal of Respiratory Medi­cine. 2026;(2):41-46
A clinical case of a combination of rheumatoid arthritis that debu­ted with the deve­lopment of bronchiectasis. Journal of Respiratory Medi­cine. 2026;(2):56-60
Application of hardware high-frequency chest wall osci­llation with focal pulsation (Respin 11) in the complex therapy of severe exacerbation of cystic fibrosis. Journal of Respiratory Medi­cine. 2026;(2):61-65
Case of targeted therapy in a patient with cystic fibrosis and deco­mpensated liver cirrhosis. Journal of Respiratory Medi­cine. 2026;(2):66-71
Abstract:

The paper presents information on possible approaches to the classification, pathogenesis, and determination of the etiological causes of bronchiectasis. It discusses a group of bronchiectasis-associated diseases. It gives a detailed diagnostic algorithm aimed to establish the etiology of bronchiectasis and the markers of the efficiency of different treatment options. Much attention is paid to genetically predetermined bronchiectasis. Universal approaches to treating patients with bronchiectasis as a whole, as well as treatments for certain entities of bronchiectasis are discussed.

Keywords:

bronchiectasis
bronchiectasia
bronchiectatic disease
cystic fibrosis
non-cystic fibrosis bronchiectasis

Authors:

Chuchalin A.G.

N.V. Sklifosovskiy Institute for Emergency Care, Moscow Health Department;
Institute of Pulmonology, Federal Medical and Biological Agency of Russia, Moscow, Russia

Close metadata

References:

  1. Ulumbekov EG. Bol'shoi entsiklopedicheskii slovar' meditsinskikh terminov. M.: Geotar-Media; 2012. (In Russ.).
  2. Tsigel'nik AYa. Bronkhoektaticheskaya bolezn'. Gosudarstvennoe izdatel'stvo meditsinskoi literatury; 1948. (In Russ.).
  3. Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and Economic Burden of Bronchiectasis. Clinical Pulmonary Medicine. 2005;12(4):205-209. doi:10.1097/01.cpm.0000171422.98696.ed
  4. Nadel J, Murray J, Masson R, Ernst J. Textbook of respiratory medicine. sixth edition. Philadelphia: Elsevier Saunders; 2014:853-877.
  5. Costerton J. The Etiology and Persistence of Cryptic Bacterial Infections: A Hypothesis. Clinical Infectious Diseases. 1984;6(Suppl.3):S608-S616. doi:10.1093/clinids/6.supplement_3.s608
  6. Mason A, Gasnier C, Kichler A et al. Enhanced Membrane Disruption and Antibiotic Action against Pathogenic Bacteria by Designed Histidine-Rich Peptides at Acidic pH. Antimicrobial Agents and Chemotherapy. 2006;50(10):3305-3311. doi:10.1128/aac.00490-06
  7. Amelina EL, Gembitskaya TE, Chermenskii AG. Osobennosti mukovistsidoza vzroslykh: obshchie voprosy. In: Mukovistsidoz: monografiya, eds. Kapranov NI, Kashirskaya NYu. M: Medpraktika; 2014:glava10. (In Russ.).
  8. Freeman A, Holland S. The Hyper-IgE Syndromes. Immunology and Allergy Clinics of North America. 2008;28(2):277-291. doi:10.1016/j.iac.2008.01.005
  9. Parr D, Guest P, Reynolds J, Dowson L, Stockley R. Prevalence and Impact of Bronchiectasis in α1-Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 2007;176(12):1215-1221. doi:10.1164/rccm.200703-489oc
  10. de Serres F. Worldwide Racial and Ethnic Distribution of α1-Antitrypsin Deficiency. Chest. 2002;122(5):1818-1829. doi:10.1378/chest.122.5.1818
  11. Lieberman J. Augmentation Therapy Reduces Frequency of Lung Infections in Antitrypsin Deficiency. Chest. 2000;118(5):1480-1485. doi:10.1378/chest.118.5.1480
  12. SHAPIRO L. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. The FASEB Journal. 2001;15(1):115-122. doi:10.1096/fj.00-0311com
  13. Chan E, Kaminska A, Gill W et al. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages. Scandinavian Journal of Infectious Diseases. 2007;39(8):690-696. doi:10.1080/00365540701225744
  14. Polivanov GE. Strukturno-densitometricheskii analiz tkani legkikh u bol'nykh KhOBL: Avtoreferat dissertatsii na soiskanie uchenoi stepeni kandidata meditsinskikh nauk. Moskva; 2008. Accessed 11 November 2016. (In Russ.). Available at: www.pulmonology.ru/publications/files/dissertations/POLIVANOv.doc
  15. Martínez-García M, de la Rosa Carrillo D, Soler-Cataluña J et al. Prognostic Value of Bronchiectasis in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 2013;187(8):823-831. doi:10.1164/rccm.201208-1518oc
  16. Noone P, Leigh M, Sannuti A et al. Primary Ciliary Dyskinesia. American Journal of Respiratory and Critical Care Medicine. 2004;169(4):459-467. doi:10.1164/rccm.200303-365oc
  17. Marchenkov IaV. Tracheal diverticula. Ter Arkh. 2013;85(10):119-121. (In Russ.).
  18. Kartalija M, Ovrutsky A, Bryan C et al. Patients with Nontuberculous Mycobacterial Lung Disease Exhibit Unique Body and Immune Phenotypes. American Journal of Respiratory and Critical Care Medicine. 2013;187(2):197-205. doi:10.1164/rccm.201206-1035oc
  19. Judge Dietz H. Marfan's syndrome. The Lancet. 2005;366(9501):1965-1976. doi:10.1016/s0140-6736(05)67789-6
  20. Reich Johnson R. Mycobacterium avium Complex Pulmonary Disease Presenting as an Isolated Lingular or Middle Lobe Pattern. Chest. 1992;101(6):1605-1609. doi:10.1378/chest.101.6.1605
  21. Perez T, Remy-Jardin M, Cortet B. Airways Involvement in Rheumatoid Arthritis. American Journal of Respiratory and Critical Care Medicine. 1998;157(5):1658-1665. doi:10.1164/ajrccm.157.5.9710018
  22. Swinson D, Symmons D, Suresh U, Jones M, Booth J. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Rheumatology. 1997;36(6):689-691. doi:10.1093/rheumatology/36.6.689
  23. Boyton R, Smith J, Jones M et al. Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clinical & Experimental Immunology. 2008;152(1):95-101. doi:10.1111/j.1365-2249.2008.03596.x
  24. Murray M, Govan J, Doherty C et al. A Randomized Controlled Trial of Nebulized Gentamicin in Non—Cystic Fibrosis Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 2011;183(4):491-499. doi:10.1164/rccm.201005-0756oc
  25. Lands LC, Stanojevic S. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Cochrane Database Syst Rev. 2007;(4):CD001505. doi:10.1002/14651858.CD001505.pub2
  26. Serisier D, Martin M, McGuckin M et al. Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non—Cystic Fibrosis Bronchiectasis. JAMA. 2013;309(12):1260. doi:10.1001/jama.2013.2290
  27. Chalmers J, McHugh B, Docherty C, Govan J, Hill A. Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax. 2012;68(1):39-47. doi:10.1136/thoraxjnl-2012-202125
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.